JPRN-UMIN000015419已完成未知
The efficacy of AST-120 on chronic kidney disease with stable angina: randomized controlled open-labeled trial - The efficacy of AST-120 on chronic kidney disease with stable angina
agoya University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2014年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with pregnancy
研究者
相似试验
Unknown
4 期
The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney DiseaseKidney Failure, ChronicNCT01157260Ewha Womans University30
已完成
4 期
Kremezin Study Against Renal Disease Progression in KoreaChronic Kidney DiseaseNCT00860431Seoul National University Hospital578
已完成
4 期
Effects of azilsartan in chronik kidney disease with hypertensiochronick kidney disease with hypertensionJPRN-UMIN000010788Division of Nephrology, Department of Internal medicine, Jichi Medical University30
已完成
不适用
The Effect of AST-120, Absorbent of Uremic Toxins on The Severity of Cardiac Failure in Patient with Chronic Heart FailureChronic heart failure with chronic renal failureJPRN-UMIN000033876AST-HF study office50
进行中（未招募）
1 期
Aspirin to target arterial events in chronic kidney disease (ATTACK)Patients with chronic kidney disease who do not have pre-existing cardiovascular diseaseMedDRA version: 20.0Level: PTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2018-000644-26-GBniversity of Southampton25,210